Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction

Cancer Immunology, Immunotherapy

Volumn 60, Issue 8, 2011, Pages 1109-1118

  Niu, Junzhou ^a   Jiang, Changli ^b   Li, Chunying ^a   Liu, Ling ^a   Li, Kai ^a   Jian, Zhe ^a   Gao, Tianwen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Foxp3; Melanoma; Treg like; Tumor resistance

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER RESISTANCE; CD4+ CD25+ T LYMPHOCYTE; COCULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TUMOR IMMUNITY; UPREGULATION; VALIDATION STUDY; WESTERN BLOTTING;

ANTIGENS, CD; ANTIGENS, CD4; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MELANOMA; RNA, SMALL INTERFERING; SKIN NEOPLASMS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES; TUMOR ESCAPE;

EID: 79960909430     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1025-3     Document Type: Article

References (33)

1. S Sakaguchi 2004 Naturally arising CD4 + regulatory t cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 531 562 15032588 10.1146/annurev.immunol.21.120601.141122 1:CAS:528:DC%2BD2cXktlOgsLo%3D (Pubitemid 38680433)
2. Y Zheng AY Rudensky 2007 Foxp3 in control of the regulatory T cell lineage Nat Immunol 8 457 462 17440451 10.1038/ni1455 1:CAS:528: DC%2BD2sXkt1Khtr8%3D (Pubitemid 46605910)
3. S Sakaguchi 2005 Naturally arising Foxp3-expressing CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 345 352 15785760 10.1038/ni1178 1:CAS:528:DC%2BD2MXisVyitLY%3D (Pubitemid 41716771)
4. D Xu H Liu M Komai-Koma C Campbell C McSharry J Alexander FY Liew 2003 CD4 + CD25 + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells. Leishmania major infection, and colitis in mice J Immunol 170 394 399 12496424 1:CAS:528:DC%2BD3sXhtFKjtQ%3D%3D (Pubitemid 36026164)
5. S Suvas U Kumaraguru CD Pack S Lee BT Rouse 2003 CD4 + CD25 + T cells regulate virus-specific primary and memory CD8 + T cell responses J Exp Med 198 889 901 12975455 10.1084/jem.20030171 1:CAS:528:DC%2BD3sXnsV2ntLo%3D (Pubitemid 37152926)
6. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942-949 (Pubitemid 39273735)
7. W Zou 2006 Regulatory T cells, tumour immunity and immunotherapy Nat Rev Immunol 6 295 307 16557261 10.1038/nri1806 1:CAS:528:DC%2BD28XivVyru7k%3D
8. M Beyer JL Schultze 2006 Regulatory T cells in cancer Blood 108 804 811 16861339 10.1182/blood-2006-02-002774 1:CAS:528:DC%2BD28XnvFajtrs%3D (Pubitemid 44154611)
9. J Dannull Z Su D Rizzieri BK Yang D Coleman D Yancey A Zhang P Dahm N Chao E Gilboa J Vieweg 2005 Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells J Clin Invest 115 3623 3633 16308572 10.1172/JCI25947 1:CAS:528:DC%2BD2MXhtlSqtLjJ (Pubitemid 43121851)
10. V Mourmouras M Fimiani P Rubegni MC Epistolato V Malagnino C Cardone E Cosci MC Nisi C Miracco 2007 Evaluation of tumour-infiltrating CD4 + CD25 + FOXP3 + regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases Br J Dermatol 157 531 539 17596146 10.1111/j.1365-2133.2007.08057.x 1:STN:280:DC%2BD2svnvVOmsw%3D%3D (Pubitemid 47256132)
11. M Viguier F Lemaitre O Verola MS Cho G Gorochov L Dubertret H Bachelez P Kourilsky L Ferradini 2004 Foxp3 expressing CD4 + CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells J Immunol 173 1444 1453 15240741 1:CAS:528:DC%2BD2cXlsVGhs70%3D (Pubitemid 38924326)
12. JD Fontenot JP Rasmussen LM Williams JL Dooley AG Farr AY Rudensky 2005 Regulatory T cell lineage specification by the forkhead transcription factor foxp3 Immunity 22 329 341 15780990 10.1016/j.immuni.2005.01.016 1:CAS:528:DC%2BD2MXjt1Ohsbk%3D (Pubitemid 40387475)
13. TA Chatila 2008 Molecular mechanisms of regulatory T-cell development Chem Immunol Allergy 94 16 28 18802333 10.1159/000154853 1:CAS:528: DC%2BD1MXhsF2gur0%3D
14. ME Brunkow EW Jeffery KA Hjerrild B Paeper LB Clark SA Yasayko JE Wilkinson D Galas SF Ziegler F Ramsdell 2001 Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse Nat Genet 27 68 73 11138001 10.1038/83784 1:CAS:528:DC%2BD3MXis1yktQ%3D%3D (Pubitemid 32044521)
15. CL Bennett J Christie F Ramsdell ME Brunkow PJ Ferguson L Whitesell TE Kelly FT Saulsbury PF Chance HD Ochs 2001 The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 20 21 11137993 10.1038/83713 1:CAS:528: DC%2BD3MXis1yluw%3D%3D (Pubitemid 32044513)
16. H Yagi T Nomura K Nakamura S Yamazaki T Kitawaki S Hori M Maeda M Onodera T Uchiyama S Fujii S Sakaguchi 2004 Crucial role of FOXP3 in the development and function of human CD25 + CD4 + regulatory T cells Int Immunol 16 1643 1656 15466453 10.1093/intimm/dxh165 1:CAS:528:DC%2BD2cXos1WqtbY%3D (Pubitemid 39480783)
17. SE Allan L Passerini R Bacchetta N Crellin M Dai PC Orban SF Ziegler MG Roncarolo MK Levings 2005 The role of 2 FOXP3 isoforms in the generation of human CD4 + Tregs J Clin Invest 115 3276 3284 16211090 10.1172/JCI24685 1:CAS:528:DC%2BD2MXhtF2kt7vK (Pubitemid 41567592)
18. CA La Porta 2009 Mechanism of drug sensitivity and resistance in melanoma Curr Cancer Drug Targets 9 391 397 19442058 10.2174/156800909788166574 1:CAS:528:DC%2BD1MXmslansb8%3D
19. DT Alexandrescu TE Ichim NH Riordan FM Marincola A Di Nardo FD Kabigting CA Dasanu 2010 Immunotherapy for melanoma: current status and perspectives J Immunother 33 570 590 20551839 10.1097/CJI.0b013e3181e032e8 1:CAS:528: DC%2BC3cXnvFymurg%3D
20. EL Korn PY Liu SJ Lee JA Chapman D Niedzwiecki VJ Suman J Moon VK Sondak MB Atkins EA Eisenhauer W Parulekar SN Markovic S Saxman JM Kirkwood 2008 Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials J Clin Oncol 26 527 534 18235113 10.1200/JCO.2007.12.7837 (Pubitemid 351264344)
21. TF Gajewski 2006 Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment Clin Cancer Res 12 2326s 2330s 16609053 10.1158/1078-0432.CCR-05-2517 1:CAS:528:DC%2BD28XjtlChsb8%3D
22. H Dong SE Strome DR Salomao H Tamura F Hirano DB Flies PC Roche J Lu G Zhu K Tamada VA Lennon E Celis L Chen 2002 Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 793 800 12091876 1:CAS:528:DC%2BD38Xls12msLo%3D
23. W Zou 2005 Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 263 274 15776005 10.1038/nrc1586 1:CAS:528:DC%2BD2MXivVars7g%3D (Pubitemid 40488632)
24. S Hinz L Pagerols-Raluy HH Oberg O Ammerpohl S Grussel B Sipos R Grutzmann C Pilarsky H Ungefroren HD Saeger G Kloppel D Kabelitz H Kalthoff 2007 Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer Cancer Res 67 8344 8350 17804750 10.1158/0008-5472.CAN-06-3304 1:CAS:528:DC%2BD2sXpvFKju7Y%3D (Pubitemid 47395173)
25. LM Ebert BS Tan J Browning S Svobodova SE Russell N Kirkpatrick C Gedye D Moss SP Ng D MacGregor ID Davis J Cebon W Chen 2008 The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells Cancer Res 68 3001 3009 18413770 10.1158/0008-5472.CAN-07-5664 1:CAS:528: DC%2BD1cXks1Ghsrg%3D (Pubitemid 351556301)
26. V Karanikas M Speletas M Zamanakou F Kalala G Loules T Kerenidi AK Barda KI Gourgoulianis AE Germenis 2008 Foxp3 expression in human cancer cells J Transl Med 6 19 18430198 10.1186/1479-5876-6-19 (Pubitemid 351712556)
27. C Chen EA Rowell RM Thomas WW Hancock AD Wells 2006 Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation J Biol Chem 281 36828 36834 17028180 10.1074/jbc. M608848200 1:CAS:528:DC%2BD28Xht1eltrbN (Pubitemid 46042151)
28. SE Allan SQ Crome NK Crellin L Passerini TS Steiner R Bacchetta MG Roncarolo MK Levings 2007 Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production Int Immunol 19 345 354 17329235 10.1093/intimm/dxm014 1:CAS:528:DC%2BD2sXjsleku7Y%3D (Pubitemid 46523383)
29. U Baron S Floess G Wieczorek K Baumann A Grutzkau J Dong A Thiel TJ Boeld P Hoffmann M Edinger I Turbachova A Hamann S Olek J Huehn 2007 DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells Eur J Immunol 37 2378 2389 17694575 10.1002/eji.200737594 1:CAS:528:DC%2BD2sXhtFahs7bE (Pubitemid 47423608)
30. C De Smet O De Backer I Faraoni C Lurquin F Brasseur T Boon 1996 The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation Proc Natl Acad Sci U S A 93 7149 7153 8692960 10.1073/pnas.93.14. 7149 (Pubitemid 26243517)
31. MA Gavin JP Rasmussen JD Fontenot V Vasta VC Manganiello JA Beavo AY Rudensky 2007 Foxp3-dependent programme of regulatory T-cell differentiation Nature 445 771 775 17220874 10.1038/nature05543 1:CAS:528:DC%2BD2sXhslSqs74%3D (Pubitemid 46279714)
32. GJ Freeman AJ Long Y Iwai K Bourque T Chernova H Nishimura LJ Fitz N Malenkovich T Okazaki MC Byrne HF Horton L Fouser L Carter V Ling MR Bowman BM Carreno M Collins CR Wood T Honjo 2000 Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J Exp Med 192 1027 1034 11015443 10.1084/jem.192.7.1027 1:CAS:528:DC%2BD3cXntFSlt7o%3D
33. K Krasagakis S Kruger-Krasagakes S Fimmel J Eberle D Tholke 1999 m von der Ohe, U. Mansmann, C.E. Orfanos, Desensitization of melanoma cells to autocrine TGF-beta isoforms, J Cell Physiol 178 179 187 1:CAS:528: DyaK1MXksVSntA%3D%3D